Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Filings indexed 2,819 across all filing types
Latest filing 2026-05-08 Regulatory Filings
Country DK Denmark
Listing CO GMAB

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Major Shareholder Announcement
Regulatory Filings
2026-05-08 Danish
Major Shareholder Announcement
Regulatory Filings
2026-05-08 Danish
Major Shareholder Announcement
Regulatory Filings
2026-05-08 Danish
6-K - GENMAB A/S (0001434265) (Filer)
Foreign Filer Report
2026-05-07 English
6-K - GENMAB A/S (0001434265) (Filer)
Foreign Filer Report
2026-04-17 English
6-K - GENMAB A/S (0001434265) (Filer)
Foreign Filer Report
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.